The Centre has tightened drug approval rules to improve patient safety. Under the revised Drugs Rules, 1945, companies submitting fake or misleading data may face licence cancellation, application rejection, and temporary debarment. The move aims to make India's drug approval process more transparent, reliable, and in line with global standards.